S

Sigilon Therapeutics, Inc.

80 employees

Sigilon Therapeutics is a biotech company that specializes in creating immune-privileged products for treating acute and chronic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
biocompatible materials
hemophilia
Wellness
biotechnology
diabetes
lysosomal storage disorders
chronic diseases
Health Care
cell therapy
cell engineering

Date founded

2015

Funding rounds raised

Total raised

$80M

from 2 investors over 2 rounds

S

Sigilon Therapeutics, Inc. raised $80M on March 17, 2020

Investors: Longevity Vision Fund and Flagship Ventures

FAQ